2021
DOI: 10.1080/07391102.2021.2011416
|View full text |Cite
|
Sign up to set email alerts
|

Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient andin silicointeraction analysis by molecular docking with Ribavirin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 129 publications
0
2
0
Order By: Relevance
“…Ribavirin showed brief interaction with two active sites of RdRp of IBDV in the current study ( Figure 6 ) which is in agreement with previous studies where ribavirin was observed to possess a weak inhibitory activity on RdRp of many RNA viruses viz. HCV, Hepatitis E virus, bovine viral diarrhea virus, vesicular stomatitis virus, influenza virus, reovirus, and HIV in vitro or in silico ( 23 , 24 , 63 ).…”
Section: Discussionmentioning
confidence: 99%
“…Ribavirin showed brief interaction with two active sites of RdRp of IBDV in the current study ( Figure 6 ) which is in agreement with previous studies where ribavirin was observed to possess a weak inhibitory activity on RdRp of many RNA viruses viz. HCV, Hepatitis E virus, bovine viral diarrhea virus, vesicular stomatitis virus, influenza virus, reovirus, and HIV in vitro or in silico ( 23 , 24 , 63 ).…”
Section: Discussionmentioning
confidence: 99%
“…Some previous studies have involved the use of software such as Pymol, Pyrex, and Protein Plus to perform docking analysis and predict molecular interactions. [6][7][8] However, no studies have specifically investigated the potential of Rosmarinic Acid as an inhibitor of Hepatitis E by interacting with the Tyrosine FYN protein. Therefore, this research fills the existing knowledge gap by presenting a comprehensive computational analysis of the interaction between Rosmarinic Acid and the target protein of Hepatitis E, which can provide a better understanding of the potential mechanism of action of this compound and serve as a basis for the development of new, more effective therapies.…”
Section: Introductionmentioning
confidence: 99%